214 related articles for article (PubMed ID: 8809141)
1. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
3. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.
Hellmark T; Johansson C; Wieslander J
Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877
[TBL] [Abstract][Full Text] [Related]
5. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
6. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
7. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
[TBL] [Abstract][Full Text] [Related]
8. Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
Segelmark M; Butkowski R; Wieslander J
Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958
[TBL] [Abstract][Full Text] [Related]
9. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen.
Kalluri R; Gunwar S; Reeders ST; Morrison KC; Mariyama M; Ebner KE; Noelken ME; Hudson BG
J Biol Chem; 1991 Dec; 266(35):24018-24. PubMed ID: 1721062
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
12. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
Katbamna I; Turner N; Ross CN; Pusey CD
J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
[TBL] [Abstract][Full Text] [Related]
13. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
Weber M; Pullig O
Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
[TBL] [Abstract][Full Text] [Related]
14. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
15. Study of EHS type IV collagen lacking Goodpasture's epitope in glomerulonephritis in rats.
Bolton WK; Luo AM; Fox PL; May WJ; Sturgill BC
Kidney Int; 1995 Feb; 47(2):404-10. PubMed ID: 7536854
[TBL] [Abstract][Full Text] [Related]
16. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
Kalluri R; Sun MJ; Hudson BG; Neilson EG
J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
[TBL] [Abstract][Full Text] [Related]
17. [Epitope mapping of anti-glomerular basement membrane antibodies].
Ding J; Zhao M; Wang H
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):863-5. PubMed ID: 11702682
[TBL] [Abstract][Full Text] [Related]
18. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
Hellmark T; Burkhardt H; Wieslander J
J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
[TBL] [Abstract][Full Text] [Related]
19. Goodpasture's epitope in development of experimental autoimmune glomerulonephritis in rats.
Bolton WK; Luo AM; Fox P; May W; Fox J
Kidney Int; 1996 Feb; 49(2):327-34. PubMed ID: 8821814
[TBL] [Abstract][Full Text] [Related]
20. Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.
Jia XY; Cui Z; Li JN; Hu SY; Zhao MH
PLoS One; 2015; 10(4):e0123277. PubMed ID: 25874890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
